Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0THOBJ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
40187444 7DC2-DM1
|
|||||
| Synonyms |
7DC2-DM1
Click to Show/Hide
|
|||||
| Organization |
Fujian Normal University.; Fujian Medical University.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.1
|
|||||
| Structure |
|
|||||
| Antibody Name |
7DC2
|
Antibody Info | ||||
| Antigen Name |
Leukocyte surface antigen CD47 (CD47)
|
Antigen Info | ||||
| Payload Name |
Mertansine DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through nucleophilic lysines
|
|||||
ADC-specific functional property(2027 Update)
Binding Affinity
| Dissocation Constant (Kd) | Binding Target | Description | Reference |
|---|---|---|---|
| 0.56 nM |
MC38-hCD47 cells (CD47)
|
Constructed 7DC-DM1 ADCs was first determined for the binding affinities (EC50 values) at the molecule level.
|
[1]
|
References